Penumbra Debt to Equity Ratio 2014-2018 | PEN
Current and historical debt to equity ratio values for Penumbra (PEN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Penumbra debt/equity for the three months ending December 31, 2018 was 0.00.
| Penumbra Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2018-12-31 | $0.00B | $0.42B | 0.00 |
| 2018-09-30 | $0.00B | $0.41B | 0.00 |
| 2018-06-30 | $0.00B | $0.43B | 0.00 |
| 2018-03-31 | $0.00B | $0.42B | 0.00 |
| 2017-12-31 | $0.00B | $0.40B | 0.00 |
| 2017-09-30 | $0.00B | $0.38B | 0.00 |
| 2017-06-30 | $0.00B | $0.37B | 0.00 |
| 2017-03-31 | $0.00B | $0.37B | 0.00 |
| 2016-12-31 | $0.00B | $0.27B | 0.00 |
| 2016-09-30 | $0.00B | $0.25B | 0.00 |
| 2016-06-30 | $0.00B | $0.25B | 0.00 |
| 2016-03-31 | $0.00B | $0.24B | 0.00 |
| 2015-12-31 | $0.00B | $0.23B | 0.00 |
| 2015-09-30 | $0.00B | $0.23B | 0.00 |
| 2015-06-30 | $0.00B | $0.00B | 0.00 |
| 2015-03-31 | $0.00B | $0.00B | 0.00 |
| 2014-12-31 | $0.00B | $0.00B | 0.00 |
| 2014-09-30 | $0.00B | $0.00B | 0.00 |
| 2013-12-31 | $0.01B | $-0.01B | -0.74 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.474B | $0.445B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $105.261B | 23.72 |
| Intuitive Surgical (ISRG) | United States | $64.748B | 60.48 |
| Edwards Lifesciences (EW) | United States | $39.266B | 40.21 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $23.664B | 16.20 |
| IDEXX Laboratories (IDXX) | United States | $18.873B | 51.39 |
| ABIOMED (ABMD) | United States | $14.572B | 96.19 |
| Teleflex (TFX) | United States | $13.884B | 30.44 |
| Hologic (HOLX) | United States | $13.648B | 20.64 |
| Varian Medical Systems (VAR) | United States | $12.581B | 31.43 |
| DexCom (DXCM) | United States | $11.613B | 444.93 |
| STERIS (STE) | United Kingdom | $10.406B | 26.74 |
| Masimo (MASI) | United States | $7.109B | 44.26 |
| Integra LifeSciences Holdings (IART) | United States | $4.712B | 22.85 |
| Globus Medical (GMED) | United States | $4.682B | 28.42 |
| LivaNova (LIVN) | United Kingdom | $4.628B | 28.53 |
| Wright Medical Group (WMGI) | Netherlands | $3.980B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $3.969B | 0.00 |
| Glaukos (GKOS) | United States | $2.896B | 0.00 |
| Cantel Medical (CMD) | United States | $2.757B | 27.41 |
| Integer Holdings (ITGR) | United States | $2.736B | 22.32 |
| Inogen (INGN) | United States | $1.966B | 39.18 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.941B | 21.08 |
| Nevro (NVRO) | United States | $1.885B | 0.00 |
| OPKO Health (OPK) | United States | $1.557B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $1.102B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $1.083B | 0.00 |
| Luminex (LMNX) | United States | $1.067B | 48.73 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.059B | 28.78 |
| Tactile Systems Technology (TCMD) | United States | $1.045B | 198.46 |
| CryoLife (CRY) | United States | $1.043B | 112.44 |
| Veracyte (VCYT) | United States | $1.006B | 0.00 |
| Intersect ENT (XENT) | United States | $0.968B | 0.00 |
| Fluidigm (FLDM) | United States | $0.938B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.875B | 35.79 |
| Natus Medical (BABY) | United States | $0.851B | 17.75 |
| AngioDynamics (ANGO) | United States | $0.811B | 26.30 |
| ViewRay (VRAY) | United States | $0.808B | 0.00 |
| AxoGen (AXGN) | United States | $0.795B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.654B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.556B | 0.00 |
| TransEnterix (TRXC) | United States | $0.482B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.462B | 48.72 |
| Si-Bone (SIBN) | United States | $0.440B | 0.00 |
| Accuray (ARAY) | United States | $0.414B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.412B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.390B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.372B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.357B | 52.09 |
| IRadimed (IRMD) | United States | $0.304B | 64.19 |
| SeaSpine Holdings (SPNE) | United States | $0.282B | 0.00 |
| Sientra (SIEN) | United States | $0.276B | 0.00 |
| Neuronetics (STIM) | United States | $0.262B | 0.00 |
| Nuvectra (NVTR) | United States | $0.206B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.188B | 43.67 |
| ConforMIS (CFMS) | United States | $0.162B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.159B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.153B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.129B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.121B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.121B | 0.00 |
| SOLITON INC (SOLY) | $0.114B | 0.00 | |
| Alphatec Holdings (ATEC) | United States | $0.114B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.106B | 0.00 |
| Vermillion (VRML) | United States | $0.103B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.088B | 0.00 |
| EDAP TMS (EDAP) | France | $0.085B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.073B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.065B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.050B | 0.00 |
| Electromed (ELMD) | United States | $0.045B | 23.17 |
| Viveve Medical (VIVE) | United States | $0.044B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.040B | 0.00 |
| Avinger (AVGR) | United States | $0.037B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.037B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.034B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.028B | 0.00 |
| PAVmed (PAVM) | United States | $0.028B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.027B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.027B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.026B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.021B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.021B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.021B | 66.67 |
| Dynatronics (DYNT) | United States | $0.017B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.016B | 12.17 |
| ReWalk Robotics (RWLK) | Israel | $0.016B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.015B | 0.00 |
| Presbia (LENS) | Ireland | $0.012B | 0.00 |
| Neovasc (NVCN) | Canada | $0.012B | 0.00 |
| Micron Solutions (MICR) | United States | $0.009B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.007B | 0.00 |
| InspireMD (NSPR) | Israel | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.002B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
